Immuron Limited (ASX:IMC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0350
0.00 (0.00%)
Jan 30, 2026, 2:39 PM AEST

Immuron Revenue

In the fiscal year ending June 30, 2025, Immuron had annual revenue of 7.29M AUD with 48.63% growth. Immuron had revenue of 1.27M in the half year ending June 30, 2024, with 108.61% growth.

Revenue
7.29M
Revenue Growth
+170.82%
P/S Ratio
1.56
Revenue / Employee
1.04M
Employees
7
Market Cap
11.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20257.29M2.38M48.63%
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.37M-94.21%
Jun 30, 20202.52M131.14K5.49%
Jun 30, 20192.39M544.52K29.55%
Jun 30, 20181.84M446.71K31.99%
Jun 30, 20171.40M395.12K39.47%
Jun 30, 20161.00M-1.30K-0.13%
Jun 30, 20151.00M21.33K2.17%
Jun 30, 2014981.05K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chimeric Therapeutics12.68M
Noxopharm2.82M
Tissue Repair2.63M
Neurotech International2.44M
Biotron1.81M
Patrys828.54K
AdAlta677.01K
Bio-Gene Technology524.37K
Revenue Rankings